Gentamicin Injection Dose, Renal Adjustment and TDM Guide

Last reviewed: 26 September 2026.

Key points

Gentamicin has a narrow therapeutic window; dose and interval depend on weight, indication, renal function and drug levels.
Nephrotoxicity, vestibular/auditory toxicity and neuromuscular blockade are major risks.
Extended-interval regimens must follow a validated local protocol and are not interchangeable with conventional label schedules.

IPLgenta-80 gentamicin injection BP 80 mg in 2 mL ampoules by Wellona Pharma, representative India-market example — Gentamicin; example brand IPLgenta-80; 80 mg/2 mL ampoules; Wellona Pharma, Surat. Image source: manufacturer product page. Representative India-market example—not an endorsement.

Indications and clinical role

Gentamicin is an aminoglycoside used for serious infections caused by susceptible Gram-negative organisms and selected combination regimens. Obtain cultures when feasible and follow antimicrobial-stewardship guidance; it is not appropriate for uncomplicated viral illness.

Official-label dosing framework

Group	Label schedule with normal renal function
Adults, serious infection	3 mg/kg/day in three equal doses every 8 hours
Life-threatening infection	Up to 5 mg/kg/day in 3–4 divided doses, reduced as soon as clinically indicated
Children	6–7.5 mg/kg/day, usually 2–2.5 mg/kg every 8 hours
Infants and neonates	7.5 mg/kg/day, usually 2.5 mg/kg every 8 hours
Premature/full-term neonates ≤1 week	5 mg/kg/day, usually 2.5 mg/kg every 12 hours

These are label schedules, not a substitute for local neonatal, sepsis or extended-interval protocols. Obesity, burns, critical illness, pregnancy and changing renal function alter pharmacokinetics.

Marketed formulations and strengths

Injectable gentamicin is commonly supplied as gentamicin sulfate equivalent to 10 mg/mL or 40 mg/mL, in ampoules or multidose vials. Indian brands and excipients vary. Check whether the product contains preservatives before neonatal or intrathecal consideration; this guide does not recommend intrathecal use.

Educational calculation example

A 12 kg child prescribed 2.5 mg/kg requires 30 mg. With a verified 40 mg/mL product, volume = 30 ÷ 40 = 0.75 mL. Independent dose/concentration checking is essential; the actual regimen requires renal assessment and local protocol.

Preparation and administration

Confirm the exact concentration; 10 mg/mL and 40 mg/mL presentations must not be confused.
For IV infusion, dilute the calculated dose in a compatible volume of 0.9% sodium chloride or 5% dextrose as permitted by the product label and infuse over about 30 minutes to 2 hours.
IM administration may be used when appropriate. Do not mix in the same solution with beta-lactam antibiotics; use separate administration and flush the line.
Use aseptic technique and inspect for particles/discolouration.

Storage, stability and compatibility

Store according to the actual pack insert, generally at controlled room temperature and protected as directed. Diluted-solution stability depends on concentration, diluent, container and manufacturer; hospital pharmacy data take priority. Physical/chemical incompatibility with penicillins and cephalosporins can occur in the same container.

Renal and hepatic considerations

Renal: obtain serum creatinine and estimate renal function before therapy and repeatedly during treatment. Reduce exposure by extending the interval and/or adjusting dose using measured concentrations. Dialysis requires a dedicated protocol. Hepatic: no routine hepatic adjustment is defined, but ascites, critical illness and hepatorenal dysfunction can change distribution and clearance.

Pregnancy and lactation

Aminoglycosides cross the placenta and may cause fetal harm; use only when the expected benefit justifies risk. Gentamicin appears in human milk in small amounts, but infant exposure and clinical context should be assessed using the current label and specialist advice.

Contraindications, interactions and monitoring

Contraindicated in serious hypersensitivity to gentamicin/aminoglycosides. Risks increase with other nephrotoxic or ototoxic medicines, potent diuretics and neuromuscular blockers. Monitor cultures/clinical response, renal function, urine output, peak/trough or protocol-defined levels, hearing/vestibular symptoms and neuromuscular status.

Adverse effects and error warnings

Important harms include acute kidney injury, tinnitus, hearing loss, vertigo, neuromuscular blockade, respiratory paralysis and hypersensitivity. Errors arise from wrong weight, confusion between strengths, decimal mistakes, failure to adjust after renal change and mistimed drug levels.

Safety warning: Actual product label, concentration और local hospital protocol verify करें। Dose, interval और TDM patient-specific हैं।

What is known—and limitations

The schedules and principal warnings above come from official labels. Many hospitals use once-daily/extended-interval dosing for selected patients, but eligibility, nomograms and targets differ; this article does not replace that protocol.

Gentamicin Injection Guide: Adult–Paediatric Dose, Renal Adjustment, Infusion and TDM